Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...

HIV's route to infection is more flexible than previously believed, study finds by Emily Kagey, Morgan Sherburne, University of Michigan edited by Lisa Lock, reviewed by Robert Egan Editors' notes ...

FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot—lenacapavir—would be given twice a year and ...

HIV and AIDS (acquired immunodeficiency syndrome) surveillance has shown that Filipinos who are newly diagnosed with HIV are getting younger. The DOH noted that the predominant age group has shifted ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

We dive into the data to get a sense of what the numbers really mean. Mind the gap In 2021, South Africa was about 1.2 million people short of its 95%-treatment goal; by 2025 the shortfall will likely ...

A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated. Developed by researchers from the Massachusetts Institute of Technology (MIT) and ...

The Philippine National AIDS Council or PNAC has assured people who want to avail themselves of the government’s free HIV testing services that their identities will be kept private.   ...

Dr. Julio Montaner, executive director of the BC Centre for Excellence in HIV/AIDS, stands outside one of Vancouver’s first indoor supervised inhalation rooms on Wednesday, Sept. 18, 2024.

In a correction issued on Sunday evening, the Quezon City local government unit (LGU) said that the 421 new HIV diagnoses it recorded from January to May 2025 are a 2.43% increase from the 411 cases ...

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the young. New research reveals older adults face comparable or higher ...